Abnormally Invasive Placenta Clinic, Fundación Valle del Lili, Cali, Colombia.
Clinical Postgraduate Department, Universidad ICESI, Cali, Colombia.
J Matern Fetal Neonatal Med. 2022 Feb;35(4):738-744. doi: 10.1080/14767058.2020.1731460. Epub 2020 Feb 23.
The main complication of the abnormally invasive placenta is massive bleeding, with transfusions required frequently. We aim to evaluate the impact of interdisciplinary management on transfusion practices in women with abnormally invasive placenta.
Clinical outcomes of women with abnormally invasive placenta treated between 2011 and 2019 were reviewed, including transfusion frequency. Patients divided into three groups: group A (women treated before the introduction of interdisciplinary management), group B (women attended to by a fixed interdisciplinary group), and group C (women with no accreta prenatal diagnosis).
Patients with prenatal diagnosis and attended by a fixed interdisciplinary group (group B) required fewer units of red blood cells to be prepared and transfused (median number of units, 0 versus 2 in group A and 3 in group C).
The participation of an interdisciplinary group, with strict standards for transfusion, reduces the frequency of use of blood substitutes during the care of women with abnormally invasive placenta.
异常性胎盘植入的主要并发症是大出血，经常需要输血。我们旨在评估多学科管理对异常性胎盘植入女性输血实践的影响。
回顾了 2011 年至 2019 年期间接受治疗的异常性胎盘植入女性的临床结果，包括输血频率。患者分为三组：A 组（在引入多学科管理之前接受治疗的女性）、B 组（由固定的多学科小组治疗的女性）和 C 组（无胎盘植入产前诊断的女性）。
有产前诊断并接受固定多学科小组治疗的患者（B 组）准备和输注的红细胞单位数量较少（中位数单位数，0 与 A 组的 2 个单位和 C 组的 3 个单位）。
多学科小组的参与，以及对输血的严格标准，减少了异常性胎盘植入女性护理过程中血液替代品的使用频率。
